ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Research Institute at Nationwide Children's Hospital / Mary Beth Ross, MD/PhD | Young Investigator Grants | 2006 | Ohio | |
Tumor cell hybridoma vaccine for recurrent neuroblastoma and Ewing sarcoma | The Pennsylvania State University / Ken Lucas, MD | Innovation Grants | 2006 | Pennsylvania |
Tyrosine Kinase Mutation Discovery in Neuroblastoma. | Dana-Farber Cancer Institute / Matthew Meyerson, MD, PhD | Innovation Grants | 2006 | Massachusetts |
Molecular characterization of OTX2 as a novel therapeutic target. | Duke University Medical Center / Hai Yan, MD | Innovation Grants | 2006 | North Carolina |
Parallel sequencing to identify the causes of childhood cancer. | Baylor College of Medicine / Sharon Plon, MD, PhD | Innovation Grants | 2006 | Texas |
HMG-I/Y in pediatric Leukemia and Lymphoma. | The Johns Hopkins University School of Medicine / Linda Smith Resar, MD | Innovation Grants | 2006 | Maryland |
Targeting Pediatric Brainstem Glioma with Oncolytic Polioviruses. | Duke University Medical Center / Matthias Gromeier, MD | Innovation Grants | 2006 | North Carolina |
Anti-Angiogenic (Metronomic) Chemotherapy in Children with Poor Prognosis. | Dana-Farber Cancer Institute / Mark Kieran, MD, PhD | Innovation Grants | 2006 | Massachusetts |
CHOA Experimental Therapy Pediatric Oncology Research. | Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta / Howard Katzenstein, MD | Phase I/II Infrastructure Grants | 2006 | Georgia |
Expanding Access to New Agents for Cancer Treatment. | Children’s Hospital Colorado / Lia Gore, MD | Phase I/II Infrastructure Grants | 2006 | Colorado |
Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents | Seattle Children’s Hospital and Regional Medical Center / Julie Park, MD | Phase I/II Infrastructure Grants | 2006 | Washington |
Building a Texas-based center for neuroblastoma clinical research. | Baylor College of Medicine / Heidi Russell, MD | Phase I/II Infrastructure Grants | 2006 | Texas |
Pediatric Oncology Translational Research Program. | Vanderbilt University Medical Center / James Whitlock, MD | Phase I/II Infrastructure Grants | 2006 | Tennessee |
New Approaches to Neuroblastoma Therapy (NANT) Consortium | Children’s Hospital Los Angeles / Robert Seeger, MD | Phase I/II Infrastructure Grants | 2006 | California |
Mediators of Metastasis in Alveolar Rhabdomyosarcoma. | University of Texas Health Science Center at San Antonio / Koichi Nishijo, MD, PhD | Young Investigator Grants | 2006 | Texas |
WIP1 Modulates Responsiveness of MB to Genotoxic Stress. | Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta / Robert Craig Castellino, MD | Young Investigator Grants | 2006 | Georgia |
Mechanisms of leukocyte recruitment to the lung during idiopathic pneumonia syndrome following allogeneic bone marrow transplantation. | Regents of the University of Michigan / Sung Won Choi, MD | Young Investigator Grants | 2006 | Michigan |
Hedgehog & IGF Signaling through IRSI in Brain Development and Medulloblastoma | Memorial Sloan-Kettering Cancer Center / Anna Marie Kenney, PhD | Young Investigator Grants | 2006 | New York |
MTG-16 Regulation by Phosphorylation | Vanderbilt University Medical Center / Michael Engel, MD, PhD | Young Investigator Grants | 2006 | Tennessee |
Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture | Children’s Hospital Los Angeles / Theresa Harned, MD | Young Investigator Grants | 2006 | California |
Pax3-FKHR targets that enable bypass of cellular senescence in rhabdomyosarcoma. | Duke University Medical Center / Corinne Mary Linardic, MD, PhD | Young Investigator Grants | 2006 | North Carolina |
Anti-Angiogenic Effects of BAI Proteins in Neuroblastoma | Children’s Hospital of Philadelphia / Naomi Balamuth, MD | Young Investigator Grants | 2006 | Pennsylvania |
Modeling osteosarcoma to identify novel therapeutic targets. | Stanford University / Julien Sage | Young Investigator Grants | 2006 | California |